GLP-1 receptor agonists e.g., semaglutide, liraglutide commonly cause gastrointestinal adverse effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation, less common risks include pancreatitis, gallbladder disease, and hypoglycemia mainly with insulin sulfonylureas
Our core values guide everything we do, including standards that ensure the quality and trustworthiness of our content and editorial processes
Treatment requires medical evaluation and prescription
GLP-1 RAs are designed to last much longer, from the time you take one dose until the time the next is due
A common side effect of GLP-1 therapy is that you feel full sooner and reduce appetite , which can change how your body responds to an alcoholic beverage
If several providers concur, mention the agreement and include full consultation letters